Cleared Traditional

K980732 - 3M CDI QUICK-CELLS WITH HEPARIN TREATMENT

K980732 is an FDA 510(k) clearance for 3M CDI QUICK-CELLS WITH HEPARIN TREATMENT, manufactured by 3M Healthcare. The device is a Class 2 Cardiovascular device with product code DRY cleared through the Traditional 510(k) pathway after a 79-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1998
Decision
79d
Days
Class 2
Risk

K980732 is an FDA 510(k) clearance for the 3M CDI QUICK-CELLS WITH HEPARIN TREATMENT. Classified as Monitor, Blood-gas, On-line, Cardiopulmonary Bypass (product code DRY), Class II - Special Controls.

Submitted by 3M Healthcare (Tistin, US). The FDA issued a Cleared decision on May 15, 1998 after a review of 79 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4330 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all 3M Healthcare devices

FDA 510(k) Submission Details - K980732

510(k) Number K980732 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 25, 1998
Decision Date May 15, 1998
Days to Decision 79 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
46d faster than avg
Panel avg: 125d · This submission: 79d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRY Device Classification - Class 2, Special Controls

Product Code DRY Monitor, Blood-gas, On-line, Cardiopulmonary Bypass
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRY Monitor, Blood-gas, On-line, Cardiopulmonary Bypass

All 34
Devices cleared under the same product code (DRY) and FDA review panel - the closest regulatory comparables to K980732.
SPECTRUM M2 MONITOR
K062468 · Spectrum Medical, Llp · Sep 2006
TRILLIUM TRI-OPTIC MEASUREMENT CELL, MODEL TMC 25T, TMC38 T, TMC 50T
K012743 · Medtronic Perfusion Systems · Sep 2001
DATA MASTER PERFUSION MONITORING SYSTEM
K001388 · Dideco · Jul 2000
3M CDI H/S CUVETTES WITH HEPARON TREATMENT
K973472 · 3M Healthcare · Dec 1997
3M CDI BLOOD PARAMETER MONITORING SYSTEM 500
K972962 · 3M Company · Nov 1997
IBC GAS CELL COMPONENTS (1/2, 3/8, 1/4)
K955379 · International Biophysics Corp. · May 1996